Efficacy and safety of luseogliflozin as monotherapy in Japanese patients with type 2 diabetes mellitus: a randomized,double-blind,placebo-controlled,phase 3 study
1. Kansai Electric Power HospitalOsakaJapan;2. Division of Translational and Molecular Medicine, Research Center for Medical Sciences, The Jikei University School of MedicineTokyoJapan;3. Yachiyo HospitalAichiJapan;4. Taisho Pharmaceutical Co. LtdTokyoJapan